Nan Liu

Department of Neurology, PLA Army General Hospital

Affiliated withPLA Army General Hospital Chongqing University Cancer Hospital

Research Area

Neuroscience Medicine

Biography

Nan Liu has not added Biography.
If you are Nan Liu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title	2018
Publication title Cited by 2	2025

Other Publications

Article	Year
Optimal Delay Time of CT Perfusion for Predicting Cerebral Parenchymal Hematoma After Intra-Arterial tPA Treatment. Frontiers in neurology\| PubMed ID: 30186221	2018
Increased expression of EZH2 indicates aggressive potential of urothelial carcinoma of the bladder in a Chinese population. Scientific reports\| PubMed ID: 30542123	2018
Higher Expression of Linc00152 Promotes Bladder Cancer Proliferation and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway. Medical science monitor : international medical journal of experimental and clinical research\| PubMed ID: 31042695	2019
GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer. OncoTargets and therapy\| PubMed ID: 31571910	2019
Efficacy and safety of Prostate stereotactic body radiotherapy for metastatic castration-resistant prostate cancer: A prospective cohort study. Cancer treatment and research communications\| PubMed ID: 33848805	2021
Circulating tumor DNA genomic profiling reveals the complicated olaparib-resistance mechanism in prostate cancer salvage therapy: A case report. World journal of clinical cases\| PubMed ID: 35611209	2022
Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arteriosclerosis. Cardiovascular research\| PubMed ID: 36464772	2023
Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer. British journal of cancer\| PubMed ID: 36681728	2023
Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer. Cancer genetics\| PubMed ID: 37487324	2023
Corrigendum to "Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer" [Cancer Genetics V... Cancer genetics\| PubMed ID: 37734143	2023
Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. Translational oncology\| PubMed ID: 37897831	2024
Deficiency of myeloid NPC1 exacerbates liver injury and fibrosis by impairing macrophage efferocytosis. Journal of advanced research\| PubMed ID: 39547438	2024
Corrigendum to "Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models" [Translational Oncology volume 39 (2024) 101803]. Translational oncology\| PubMed ID: 39848760	2025
Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer. Journal of translational medicine\| PubMed ID: 40012053	2025